The re-run of our MBCTALKS webinar “Connecting MBC experts to disclose and discuss 1st line treatment setting in patients with HR+ HER2- MBC” is approaching on November 24th!
We invite you to participate in our live event with Prof. Carlos Barrios (Brazil), Prof. Matteo Lambertini (IT) and Prof. Michael Gnant (AU)! The experts will share the latest data for CDK4 & 6 inhibitors combined with AIs for patients with HR+ HER2- MBC in the 1st line setting and exchange clinical experience in managing patients with HR+ HER2- MBC who require 1st line therapy.
Are you interested in participating? Then register now for the November 24th, 2022, at 10am, 1pm or 5pm!
Prof. Michael Gnant: Full Professor of Surgery, Medical University of Vienna, Austria
Prof. Carlos Barrios: Adjunct Assistant Professor, University of Miami School of Medicine, USA
Prof. Matteo Lambertini: Associate Professor in medical oncology, IRCCS O. P. San Martino, Italy
Session 1: 10:00-10:45am
Session 2: 1:00-1:45pm
Session 3: 5:00-5:45pm